reference standard raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-06 and is reviewed periodically as new material appears.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Tirzepatide 是一种由 39 个氨基酸组成的合成肽，分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰，使其能够同时与葡萄糖依赖性促胰岛素多肽（GIP）受体和胰高血糖素样肽-1（GLP-1）受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道，随后进入糖尿病与体重管理领域的临床研究。
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
| Property | Value | Notes |
|---|---|---|
| Primary purity method | Reversed-phase HPLC | Ultraviolet detection near 214 nm |
| Identity confirmation | Intact mass by LC-MS | Compared with theoretical average mass |
| Sequence verification | Enzymatic peptide mapping | Tandem mass spectrometry of fragments |
| Common degradation route | Deamidation and oxidation | Rate increases with pH and temperature |
| Reference material | Lyophilized peptide standard | Stored desiccated below -20 °C |
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Lipasen sind Enzyme, die von Lipiden wie Glyceriden oder Cholesterinestern freie Fettsäuren abspalten (Lipolyse). Diese Enzyme spielen physiologisch eine wichtige Rolle, indem sie Fette verdauen und so die im Körper gespeicherten Fettreserven verfügbar machen. Außerdem gibt es eine Unzahl technischer Anwendungen für diese Proteine. Im engeren Sinn bezeichnet Lipase in der medizinischen Diagnostik die pankreasspezifische enterale Lipase (Pankreaslipase).
== Geschichte == 1834 erkannte Johann Nepomuk Eberle, dass Pankreassekrete Öle in Wasser emulgieren können. Aufbauend auf dieser Erkenntnis fand Claude Bernard 1846 heraus, dass bei diesem Vorgang eine saure Reaktion abläuft. Zunächst wurde das Enzym als "Ferment émulsif" bezeichnet, 1896 nannte Maurice Hanriot (1854–1933) es dann Lipase. Dies wurde später der Sammelbegriff für die gesamte Gruppe. Marcel von Nenecki (1847–1901) zeigte, dass die Lipasen des Pankreas von der Galle aktiviert werden müssen.
== Struktur echter Lipasen EC 3.1.1.3 == Die Esterasen unterscheiden sich in ihrem Substratspektrum. Demnach bevorzugen Lipasen lipophile, wasserunlösliche Substrate. Sie sind aber auch in der Lage, Triglyceride aus kurzkettigen Fettsäuren umzusetzen, die noch begrenzt wasserlöslich sind. Im Gegensatz dazu hydrolysieren die anderen Esterasen nur kurzkettige, wasserlösliche Substrate. Außerdem unterscheiden sich die Esterasen von den Lipasen durch ihre Proteinstrukturen. Lipasen haben einen Deckel (engl. lid) über dem aktiven Zentrum, welcher bei Esterasen fehlt. Die Lipasen kommen außerdem in allen Tieren, Pflanzen und Mikroorganismen als zelluläre oder extrazelluläre Proteine vor. Sie gehören zur Familie der Serin-Hydrolasen und haben für ihre spezifischen Reaktionen ein Reaktionsgleichgewicht, das vom Wassergehalt des Gesamtsystems abhängig ist. Ein weiterer wichtiger Unterschied zu Esterasen ist der, dass die Hydrolyse von Esterbindungen von Glycerinestern an einer Öl-Wasser-Grenzfläche stattfindet. Lipasen besitzen oft keine klaren Übereinstimmungen in der Aminosäurensequenz. Bei Betrachtung der räumlichen Struktur hingegen wird klar, dass Lipasen gemeinsame Formen aufweisen. Demnach bilden die Lipasen eine Familie von α/β-Hydrolase-Faltungen, die bei allen Lipasen vorhanden ist. Sie besteht darin, dass im Zentrum der Lipasen acht nahezu parallel angeordnete β-Faltblätter platziert sind, die wiederum von α-Helices eingeschlossen sind, mit Ausnahme des zweiten β-Faltblattes, welches zudem invers in die Struktur eingeordnet ist.
Mit wenigen Ausnahmen liegen die Aminosäuren, die für die katalytische Wirkung der Lipasen verantwortlich sind, an denselben Positionen. Diese Aminosäuren bilden eine katalytische Triade, die normalerweise aus den Aminosäuren Serin, Histidin und Asparaginsäure gebildet wird. Diese Triade ist funktionell, aber nicht strukturell verwandt mit der von Trypsin und Subtilisin. In der Aminosäurensequenz von α/β-Hydrolasen erscheinen die Aminosäuren in der folgenden Reihenfolge: Serin, Asparaginsäure, Histidin. Das Serin kommt üblicherweise im konservierten Pentapeptid von Gly-Xaa-Ser-Xaa-Gly vor.
Sources: de.wikipedia.org
Peptide mapping with tandem mass spectrometry is the standard approach. The peptide is digested with an enzyme such as trypsin, and the resulting fragments are matched against the expected sequence.
Higher pH and elevated temperature both increase deamidation rates. Holding solutions at low temperature and near-neutral to slightly acidic pH reduces the extent of the reaction.
Removing water slows hydrolysis and aggregation. The dry powder tolerates longer storage intervals than a solution kept at the same temperature.
它属于合成修饰肽，同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂，与选择性 GLP-1 激动剂在靶点范围上不同。